Proffitt, Calvin
- Leidos Biomedical Research, Inc. (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #81
- Top 1% Funded
- Early Career
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2022 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2023
Linked Award Amount
$19.4M
Full award amounts, FY2023
Award Records
2
Records listing this PI
Award-Linked Rank
#81
By linked amount among FY2023 PIs
Earliest Year Loaded
2022
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Proffitt, Calvin as a PI. Multi-PI records show the full award amount for context.
- 261201500003I-P00013-26100059-4N01Contact PILEIDOS FUNDING TO59, OPTION 4 SUPPORT RESEARCH LAB AND BIOREPOSITORY IN LIBERIA$10.9Maward amount
- 261201500003I-P00013-26100059-5N01Contact PILEIDOS FUNDING TO59, OPTION 1 ONE ADDITIONAL SITE IN THE DRC$8.5Maward amount
Award organization
Organizations that administered FY2023 awards listing Proffitt, Calvin as a PI.
FY2023 award administered by Leidos Biomedical Research, Inc. (MD).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2022First NIH AwardLeidos Biomedical Research, Inc.
- 2022$500K Cumulative Funding
- 2022$1M Cumulative Funding
- 2022$2M Cumulative Funding
- 2022Entered Top 50% NationallyRanked #773
- 2022Entered Top 25% NationallyRanked #773
- 2022Entered Top 10% NationallyRanked #773
- 2022Entered Top 5% NationallyRanked #773
- 2023$5M Cumulative Funding
- 2023$10M Cumulative Funding
- 2023Entered Top 1% NationallyRanked #81